Cargando…
Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative disease that gradually impairs cognitive functions. Recently, there has been a conceptual shift toward AD to view the disease as a continuum. Since AD is currently incurable, effective intervention to delay or prevent pathological cognitive declin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106168/ https://www.ncbi.nlm.nih.gov/pubmed/36914945 http://dx.doi.org/10.1097/CM9.0000000000002566 |